Newark, DENCT06907173Now EnrollingIRB Ready

Status Epilepticus Clinical Trial in Newark, DE

Access cutting-edge status epilepticus treatment through this clinical trial at a research site in Newark. Study-provided care at no cost to qualified participants.

Sponsored by University of Virginia

Quick Self-Assessment

See if you qualify for this Newark location

Preparing your pre-screening questions…

Expert Care in Newark

Access status epilepticus specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related status epilepticus treatment provided free

Apply for This Newark Location

Check if you qualify for this status epilepticus clinical trial in Newark, DE

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Newark

    Convenient for DE residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Newark site if eligible
  4. 4Begin participation

About This Status Epilepticus Study in Newark

The goal of this clinical trial is to determine if treatment of patients with two doses of ketamine plus levetiracetam versus levetiracetam alone leads to more effective control of status epilepticus.

Sponsor: University of Virginia

Who Can Participate

Inclusion Criteria

The patient was witnessed to have a convulsive seizure for greater than 5-minute duration
The patient received an adequate dose of benzodiazepines. The doses may be divided.
The last dose of a benzodiazepine was administered 5-30 minutes before study drug administration.
Continued or recurring seizures in the Emergency Department.
Age 1 years or older
Known or estimated weight ≥10 Kg

Exclusion Criteria

Known pregnancy
Opt-out identification or otherwise known to be previously enrolled in KESETT
Treatment with a second line anticonvulsant (FOS, PHT, VPA, LEV, phenobarbital, or other agents defined in the MoP) for this episode of SE
Treatment with sedatives with anticonvulsant properties other than benzodiazepines for this episode of SE(propofol, etomidate, ketamine or other agents defined in the MoP)
Endotracheal intubation prior to enrollment
Acute traumatic brain injury clearly precedes seizures
Scalp injury or burn preventing EEG placement
Known allergy or other known contraindication to KET or LEV
Hypoglycemia \< 50 mg/dL
Hyperglycemia \> 400 mg/dL
Cardiac arrest / post-anoxic seizures

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Newark?

Yes, this clinical trial (NCT06907173) has an active research site in Newark, DE that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Status Epilepticus Treatment Options in Newark, DE

If you're searching for status epilepticus treatment options in Newark, DE, this clinical trial (NCT06907173) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Newark research site is actively enrolling participants for this clinical trial. You'll receive care from experienced status epilepticus specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all status epilepticus clinical trials near you to find additional studies recruiting in your area.

More Epilepsy Trials in Newark, DE

See all epilepsy clinical trials recruiting in Newark — not just this study.

Browse Epilepsy Trials in Newark →

Browse More Trials by Condition

Epilepsy TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Newark?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Newark, DE